- Home
- ALUR
as 07-26-2024 4:00pm EST
Stocks
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | NATICK |
| Market Cap: | 72.4M | IPO Year: | N/A |
| Target Price: | $5.00 | AVG Volume (30 days): | 496.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.70 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.81 - $10.94 | Next Earning Date: | 08-13-2024 |
| Revenue: | $48,781,000 | Revenue Growth: | -25.60% |
| Revenue Growth (this year): | 4.92% | Revenue Growth (next year): | 43.64% |
Latest Allurion Technologies Inc. News
ALUR Breaking Stock News: Dive into ALUR Ticker-Specific Updates for Smart Investing
Business Wire
10 days ago
Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024
Business Wire
a month ago
Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement
Business Wire
a month ago
Allurion Announces Launch of Offering of Common Stock and Warrants
Business Wire
a month ago
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
ACCESSWIRE
a month ago
Sidoti Events, LLC's Virtual June Small-Cap Conference
Zacks
a month ago
Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Business Wire
2 months ago
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
Yahoo Finance Video
2 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
Compare ALUR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALUR Allurion Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.